The transition to IFRS 17, which became mandatory for insurance contracts on January 1, 2023, has now completed its second full reporting cycle. What initially appeared as a purely technical accounting change has revealed itself as a catalyst for strategic transformation across the global insurance industry.
The Measurement Revolution
IFRS 17 replaced a patchwork of national accounting standards with a unified framework based on current-value measurement of insurance liabilities. The Contractual Service Margin (CSM), which represents the unearned profit embedded in insurance contracts, has become the central metric through which analysts and investors evaluate insurer performance.
The shift from premium-based to margin-based performance measurement has had profound implications. Insurers that generate consistent, predictable CSM amortisation — typically those with diversified portfolios of long-duration contracts — have been rewarded with valuation premiums. Conversely, companies with volatile short-tail books have faced greater scrutiny of their earnings quality.
Strategic Consequences
The CSM framework has influenced product design, pricing, and portfolio strategy. Several major insurers have reported adjustments to their product mix, favouring contracts that generate more favourable CSM recognition patterns. Life insurers with large books of participating and unit-linked business have generally benefited from IFRS 17, as the framework recognises the value of these complex products more transparently.
In property and casualty insurance, the Premium Allocation Approach (PAA) has provided a simplified measurement model for short-duration contracts. However, the requirement to recognise onerous contracts immediately has increased earnings volatility for insurers with concentrated catastrophe exposures, particularly in the quarters following major loss events.
Investor Communication
The insurance sector’s relationship with equity analysts and institutional investors has been fundamentally altered. The granularity of IFRS 17 disclosures — including the CSM roll-forward, the disaggregation of insurance revenue, and the explicit separation of insurance service result from investment returns — has provided investors with substantially more insight into underlying performance.
However, this transparency has also created challenges. The complexity of IFRS 17 reporting has raised the bar for investor relations teams, and several insurers have reported that analyst coverage has become more concentrated among specialists who can navigate the new framework. The broader generalist investment community has been slower to adapt.
Remaining Challenges
Despite two years of implementation experience, significant challenges persist. Comparability between companies remains limited due to differences in the application of key judgements, particularly regarding discount rates, risk adjustments, and the boundary of insurance contracts. Regulatory capital frameworks, which remain based on Solvency II or local equivalents, do not always align with IFRS 17 measurement, creating dual-reporting burdens.
The interaction between IFRS 17 and IFRS 9 (financial instruments) continues to generate implementation questions, particularly for life insurers with complex asset-liability management strategies. The accounting mismatch between insurance liabilities measured under IFRS 17 and financial assets measured under IFRS 9 requires careful hedge accounting and other-comprehensive-income (OCI) election decisions.